drugset / Trial / NCT05110768
Treatment of (IDA) by (FPC) Delivered Via Infusion Pump in Patients Receiving Home Infusion Therapy
RandomizedParallel-groupOpen-labelTreatment
Summary
The main purpose is to determine whether FPC, administered via infusion, is safe and effective for the treatment of iron deficiency anemia (IDA) in patients receiving Home Infusion therapies (HI).
Timeline
- Start
- 2021-11-30
- Primary completion
- 2022-04-30
- Completion
- 2022-05-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Triferic | Other / unclassified | 20 mg | Intravenous |